Starpharma Holdings Limited has released a press release.
Entitlement Offer Investor Presentation
Earlier from Starpharma
- DEP milestone triggers partner option fee
- Positive DEP HER2-Lu preclinical data support Phase 1 entry
- FDA confirms path to DEP HER2 first-in-human study
- Half Yearly Report and Accounts